USPTO serial 90809450
HELICO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- YAO, GRETTA
- Law office
- TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with HELICO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Viola Kung
VIOLA KUNG PERKINS COIE LLPP.O. BOX 2608SEATTLE, WA 98111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Preparations, namely, compounds produced by stable transgenic plant lines; preparations, namely, biologics, biosimilars, and pharmaceuticals produced by stable transgenic plant lines with therapeutic applications; preparations, namely, chemical compounds, biosurfactants, and lubricants produced by stable transgenic plant lines with industrial applications; preparations, namely, pesticides, fertilizers, and reducers of carbon emissions produced by stable transgenic plant lines with environmental or agrochemical applications; stable transgenic plant lines developed to produce and/or purify molecules of interest; molecular tools for allowing expression of genes and/or molecules in planta; customized plant strains created using molecular tools; customized plant strains engineered to produce specific compounds; customized plant strains engineered to produce small molecules, peptides, or proteins that can be used for medical or veterinary purposes; plant development platform for producing genetically modified platforms that have been engineered to create specific compounds; therapeutic molecules for medical or veterinary preparations; pharmaceuticals | ACTIVE | — |
| 042 | Biotechnology research; biotechnology services, namely, research and development in the area of transgenic plant lines; research and development in relation to compound production; research and development in relation to transgenic plant lines; research and development in relation to the engineering of transgenic plant lines customized to produce compounds; product development services for others in the area of biotechnology for research, clinical, therapeutic, and manufacturing purposes; compound production services for scientific, research, clinical, therapeutic, and manufacturing purposes; consultancy relating to compound production; laboratory research in the fields of engineered plant strains, compound production, and molecular purification; development of software-implemented algorithms for biotechnology and chemistry purposes; development of software-implemented algorithms for molecular visualization; development of software-implemented algorithms for predicting biological, chemical, and molecular interactions; development of software-implemented databases containing information regarding molecular functions and interactions; research services for medical purposes; consultancy services in relation to biotechnology research, development, and production; consultancy services in relation to modeling of molecular interactions; consultancy services in relation to creating customized plant varieties | ACTIVE | — |
| 044 | Preparation of compounds with therapeutic applications; preparations for treating medical conditions, namely, biologics, biosimilars, and pharmaceuticals produced by stable transgenic plant lines; production of therapeutic compounds using stable transgenic plant lines; providing a database with information regarding plant strains engineered to produce compounds with therapeutic applications; providing a database with information regarding chemo-informatic tools that allow biological, chemical, and molecular interactions to be predicted; plant engineering services; services related to the development of transgenic plant lines; medical services, namely, providing therapies for treating ailments; veterinary services, namely, providing therapies for treating ailments; consultation services related to the research, development, and production of compounds with therapeutic applications; preparation of compounds with agricultural applications | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 14, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 14, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 14, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2021 | NWAP | NEW APPLICATION ENTERED | — |